Literature DB >> 19179849

Relative potency and effectiveness of flunitrazepam, ethanol, and beta-CCE for disrupting the acquisition and retention of response sequences in rats.

Stuart T Leonard1, Lisa R Gerak, Marcus S Delatte, Joseph M Moerschbaecher, Peter J Winsauer.   

Abstract

Despite the knowledge that gamma-aminobutyric acid(A) modulators can affect learning and memory, their capacity for disrupting each of these complex processes is rarely compared, and often mistakenly assumed to occur with identical potency. For these reasons, the effects of flunitrazepam (0.056-3.2 mg/kg), ethanol (0.25-1.5 g/kg), and ethyl-beta-carboline-3-carboxylate (beta-CCE; 1-17.8 mg/kg) were compared in groups of rats responding under baselines that assessed learning and memory separately. The first baseline was a multiple schedule of repeated acquisition and performance of tandem response sequences, whereas the second baseline was a retention or memory procedure where a tandem response sequence was acquired and then retested after a 30-min delay. Under both procedures, responding was maintained under a second-order fixed-ratio-2 schedule of food reinforcement, and incorrect responding (errors) produced a 5-s timeout. With regard to the effects of the three drugs on sequence acquisition (learning), all three drugs dose dependently decreased the overall response rate and increased the percentage of errors. Both flunitrazepam and beta-CCE affected accuracy more potently than response rate, whereas ethanol was equipotent in affecting these two dependent measures. With regard to the effects of these drugs on sequence retention (memory), both flunitrazepam and ethanol dose dependently decreased retention at doses that had little or no effect on sequence acquisition under the multiple schedule, whereas beta-CCE decreased retention and sequence acquisition similarly at the doses tested. Together, these data show that drugs with differing capacities for altering the function of gamma-aminobutyric acid(A) receptors differ in their capacity for disrupting the acquisition and retention of response sequences and that positive modulation of this receptor complex may be more predictive of disruptions in memory than disruptions in learning.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19179849      PMCID: PMC2752368          DOI: 10.1097/FBP.0b013e3283242f2d

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  37 in total

1.  Anterograde and retrograde amnesia after lormetazepam and flunitrazepam.

Authors:  H Ott; A Rohloff; B Aufdembrinke; K Fichte
Journal:  Psychopharmacol Ser       Date:  1988

2.  Models of memory dysfunctions.

Authors:  H Weingartner
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

3.  Effects of competitive and noncompetitive GABA(A) antagonists on the acquisition of a discrimination in squirrel monkeys.

Authors:  E.D. Pakarinen; J.M. Moerschbaecher
Journal:  Behav Pharmacol       Date:  1995-03       Impact factor: 2.293

4.  Beta-carboline interactions at the BZ-GABA receptor chloride-ionophore complex in the rat cerebral cortex.

Authors:  E Malatynska; R Knapp; M Ikeda; H I Yamamura
Journal:  Brain Res Bull       Date:  1989-05       Impact factor: 4.077

Review 5.  Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.

Authors:  Guy Chouinard
Journal:  J Clin Psychiatry       Date:  2004       Impact factor: 4.384

Review 6.  Memory, benzodiazepines, and anxiety: integration of theoretical and clinical perspectives.

Authors:  J G Barbee
Journal:  J Clin Psychiatry       Date:  1993-10       Impact factor: 4.384

Review 7.  The role of GABA(A) receptors in the acute and chronic effects of ethanol.

Authors:  A C Grobin; D B Matthews; L L Devaud; A L Morrow
Journal:  Psychopharmacology (Berl)       Date:  1998-09       Impact factor: 4.530

8.  Effects of phencyclidine, pentobarbital, and d-amphetamine on the acquisition and performance of conditional discriminations in monkeys.

Authors:  J M Moerschbaecher; D M Thompson
Journal:  Pharmacol Biochem Behav       Date:  1980-12       Impact factor: 3.533

9.  Regulation of allosteric coupling and function of stably expressed gamma-aminobutyric acid (GABA)A receptors by chronic treatment with GABAA and benzodiazepine agonists.

Authors:  R L Klein; M P Mascia; P C Harkness; K L Hadingham; P J Whiting; R A Harris
Journal:  J Pharmacol Exp Ther       Date:  1995-09       Impact factor: 4.030

10.  The effect of benzodiazepines and beta-carbolines on GABA-stimulated chloride influx by membrane vesicles from the rat cerebral cortex.

Authors:  T Obata; H I Yamamura
Journal:  Biochem Biophys Res Commun       Date:  1986-11-26       Impact factor: 3.575

View more
  5 in total

1.  Learning by subtraction: Hippocampal activity and effects of ethanol during the acquisition and performance of response sequences.

Authors:  Myles J Ketchum; Theodore G Weyand; Peter F Weed; Peter J Winsauer
Journal:  Hippocampus       Date:  2015-11-05       Impact factor: 3.899

2.  Effects of pregnanolone and flunitrazepam on the retention of response sequences in rats.

Authors:  Russell J Amato; Joseph M Moerschbaecher; Peter J Winsauer
Journal:  Pharmacol Biochem Behav       Date:  2011-05-27       Impact factor: 3.533

3.  Comparison of the behavioral and cardiovascular effects of mephedrone with other drugs of abuse in rats.

Authors:  Kurt J Varner; Kyle Daigle; Peter F Weed; Peter B Lewis; Sarah E Mahne; Ananthakrishnan Sankaranarayanan; Peter J Winsauer
Journal:  Psychopharmacology (Berl)       Date:  2012-09-13       Impact factor: 4.530

4.  Superadditive effects of ethanol and flunitrazepam: implications of using immunopharmacotherapy as a therapeutic.

Authors:  Jennifer B Treweek; Amanda J Roberts; Kim D Janda
Journal:  Mol Pharm       Date:  2010-09-17       Impact factor: 4.939

5.  Effect of flunitrazepam as an oral hypnotic on 24-hour blood pressure in healthy volunteers.

Authors:  Daniele Bosone; Roberto Fogari; Annalisa Zoppi; Angela D'Angelo; Natascia Ghiotto; Giulia Perini; Matteo Cotta Ramusino; Alfredo Costa
Journal:  Eur J Clin Pharmacol       Date:  2018-04-30       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.